All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Attilio Olivieri discusses extracorporeal photopheresis in acute and chronic GvHD
Extracorporeal photopheresis in acute and chronic GvHD
Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease
This study indicates that ECP is safe and effective for the treatment of GvHD, especially if it is administered early.
The role of CD56bright natural killer cells in extracorporeal photopheresis
CD56bright NK cells may increase in patients with GvHD who respond to ECP therapy and may correlate with response rates. The researchers prospectively studied blood subsets...
Subscribe to get the best content related to GvHD delivered to your inbox